{
  "id": 20689090,
  "title": "Coreline Soft to Unveil ‘One CT Scan, Multiple Diseases’ Strategy at RSNA 2026",
  "url": "https://urgent.news/2026/11/19/coreline-soft-to-unveil-one-ct-scan-multiple-diseases-strategy-at",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-19T02:14:51.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=159304"
  },
  "original_language": "en",
  "account": null,
  "summary": "Coreline Soft, a medical AI company from South Korea, will unveil its \"One CT Scan, Multiple Diseases\" strategy at the Radiological Society of North America's (RSNA) 2026 annual meeting in Chicago. The company's chest CT-based AI platform, AVIEW, aims to extract quantitative information on various lung and cardiovascular conditions from a single CT examination, extending its clinical value beyond pulmonary nodule detection to include emphysema, COPD, CAC, and ILA. The company will showcase five products from its AVIEW portfolio, including AVIEW LCS for pulmonary nodule detection, AVIEW Lung Nodule CAD for automated pulmonary nodule detection, AVIEW COPD for quantitative analysis of emphysema and airways, AVIEW CAC for coronary artery calcification measurement, and AVIEW Aorta Metrics for aortic diameter analysis. AVIEW has received FDA 510(k) clearance for AVIEW Aorta Metrics, bringing the company's total number of FDA clearances to 13, and is currently used at over 500 healthcare institutions across 19 countries, with more than 3.5 million imaging examinations analyzed by the platform.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}